Heron Therapeutics Inc (HRTX) Stock Price, Quote, News & History

HRTXNASDAQ
$0.3039
-0.0192-5.93%
Last update: Aug 26, 11:14 AM

Financials

Quarterly
Annual
Name
Revenue
Change
Gross
Change
EBITDA
Change
EBIT
Change
Earnings
Change

Cash Flows

Operating Cash Flow (TTM)
-11.61M
Investing Cash Flow (TTM)
2.20M
Financing Cash Flow (TTM)
13.61M
Free Cash Flow (TTM)
-12.14M
Capital Expenditure (TTM)
-529.00K
Net Change in Cash (TTM)
4.21M

Analyst Trends and Forecast

1
Jun
1
Aug
Buy
Hold
Sell
Strong Sell

Analyst Rating and Forecast

12345
4.3
Buy
Strong Buy
Buy
Hold
Sell
Strong Sell

Valuation Metrics

Enterprise Value
$168.06M
PE Ratio (TTM)
-
PE Ratio (FWD)
-
PEG Ratio (TTM)
-
PS Ratio (TTM)
0.39
PB Ratio (TTM)
10.47
Earnings Yield % (TTM)
-58.82%
Earnings Yield % (FWD)
-27.86%
EV / EBITDA (TTM)
-
Price / EBITDA (TTM)
-
Price / Free Cash Flow (TTM)
-
Book Value / Share
$0.03

Company Debt

Total Debt
$142.65M
LT Debt
$142.65M
LT Debt Issuance (TTM)
-
LT Debt Repayment (TTM)
-
Total Cash
$20.72M
Debt to Equity
25.33
Issuance of Debt (TTM)
-
Repayment of Debt (TTM)
-

Key Statistics

Open
$0.32
Close
-
Volume / Avg.
1.04M / 3.48M
Day Range
$0.30 - $0.32
52 Wk Range
0.30 - 1.58
Market Cap
$57.71M
P/E Ratio
-
Dividend Yield
-
Exchange
NASDAQ
RSI
30
Short Interest
31.36%
Days to Cover
12.33

About

Sector
Health Care
Industry
Biotechnology
Heron Therapeutics Inc is a commercial-stage biotechnology company. The company is focused on improving the lives of patients by developing treatments and commercializing therapeutic solutions to address some of the unmet patient needs. The company's...
Show More
Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

FAQ

Q

How do I buy Heron Therapeutics (HRTX) stock?

A

You can purchase shares of Heron Therapeutics (NASDAQ:HRTX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Heron Therapeutics (HRTX) competitors?

Q

What is the forecast, or price target, for Heron Therapeutics (HRTX) stock?

A

Heron Therapeutics has a consensus price target of $6.50.

Q

What is the current price for Heron Therapeutics (HRTX)?

A

The stock price for Heron Therapeutics (NASDAQ: HRTX) is $0.30395 last updated August 26, 2026 at 11:14 AM EDT.

Q

Does Heron Therapeutics (HRTX) pay a dividend?

A

There are no upcoming dividends for Heron Therapeutics.

Q

When is Heron Therapeutics (NASDAQ:HRTX) reporting earnings?

A

Heron Therapeutics does not have any upcoming earnings scheduled.

Q

Is Heron Therapeutics (HRTX) going to split?

A

There is no upcoming split for Heron Therapeutics.

Q

What sector and industry does Heron Therapeutics (HRTX) operate in?

A

Heron Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.